|
UBTD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.980400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.499100E-03 |
| Normal-vs-Stage2 |
4.823800E-02 |
| Normal-vs-Stage3 |
7.341500E-03 |
| Normal-vs-Stage4 |
3.184900E-04 |
| Stage1-vs-Stage2 |
8.748200E-01 |
| Stage1-vs-Stage3 |
6.898200E-01 |
| Stage1-vs-Stage4 |
9.403800E-02 |
| Stage2-vs-Stage3 |
6.939600E-01 |
| Stage2-vs-Stage4 |
1.382810E-01 |
| Stage3-vs-Stage4 |
2.452200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.003600E-03 |
| Normal-vs-AfricanAmerican |
1.105580E-01 |
| Normal-vs-Asian |
5.278300E-02 |
| Caucasian-vs-AfricanAmerican |
8.172800E-01 |
| Caucasian-vs-Asian |
8.005200E-01 |
| AfricanAmerican-vs-Asian |
9.704800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.444000E-03 |
| Normal-vs-Female |
4.978500E-03 |
| Male-vs-Female |
7.981000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.834490E-02 |
| Normal-vs-Age(41-60Yrs) |
6.062600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.058460E-03 |
| Normal-vs-Age(81-100Yrs) |
4.926200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.468600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.567850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.702400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.622200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.462600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.495800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.788650E-01 |
| Classical-VS-Follicular |
4.208100E-02 |
| Classical-VS-Other |
6.359400E-01 |
| Classical-VS-Normal |
3.744100E-02 |
| Tall-VS-Follicular |
9.789800E-01 |
| Tall-VS-Other |
8.530200E-01 |
| Tall-VS-Normal |
9.281800E-03 |
| Follicular-VS-Other |
8.517400E-01 |
| Follicular-VS-Normal |
1.457350E-03 |
| Other-VS-Normal |
2.016400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.882000E-03 |
| Normal-vs-N1 |
1.162540E-03 |
| N0-vs-N1 |
4.058400E-01 |
|
|
